Literature DB >> 12527216

HIV-1 entry inhibitors: new targets, novel therapies.

Theodore C Pierson1, Robert W Doms.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12527216     DOI: 10.1016/s0165-2478(02)00235-3

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


× No keyword cloud information.
  11 in total

1.  A small molecule HIV-1 inhibitor that targets the HIV-1 envelope and inhibits CD4 receptor binding.

Authors:  Pin-Fang Lin; Wade Blair; Tao Wang; Timothy Spicer; Qi Guo; Nannan Zhou; Yi-Fei Gong; H-G Heidi Wang; Ronald Rose; Gregory Yamanaka; Brett Robinson; Chang-Ben Li; Robert Fridell; Carol Deminie; Gwendeline Demers; Zheng Yang; Lisa Zadjura; Nicholas Meanwell; Richard Colonno
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-20       Impact factor: 11.205

2.  Isolation and characterization of human immunodeficiency virus type 1 resistant to the small-molecule CCR5 antagonist TAK-652.

Authors:  Masanori Baba; Hiroshi Miyake; Xin Wang; Mika Okamoto; Katsunori Takashima
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

Review 3.  Vaginal microbicides: a novel approach to preventing sexual transmission of HIV.

Authors:  Gustavo Doncel; Christine Mauck
Journal:  Curr HIV/AIDS Rep       Date:  2004-04       Impact factor: 5.071

4.  Biochemical and genetic characterizations of a novel human immunodeficiency virus type 1 inhibitor that blocks gp120-CD4 interactions.

Authors:  Qi Guo; Hsu-Tso Ho; Ira Dicker; Li Fan; Nannan Zhou; Jacques Friborg; Tao Wang; Brian V McAuliffe; Hwei-Gene Heidi Wang; Ronald E Rose; Hua Fang; Helen T Scarnati; David R Langley; Nicholas A Meanwell; Ralph Abraham; Richard J Colonno; Pin-Fang Lin
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

5.  In vivo evolution of X4 human immunodeficiency virus type 1 variants in the natural course of infection coincides with decreasing sensitivity to CXCR4 antagonists.

Authors:  Evelien H B Stalmeijer; Ronald P Van Rij; Brigitte Boeser-Nunnink; Janny A Visser; Marloes A Naarding; Dominique Schols; Hanneke Schuitemaker
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

6.  Chicken heat shock protein 90 is a component of the putative cellular receptor complex of infectious bursal disease virus.

Authors:  Ta-Wei Lin; Chi-Wen Lo; Su-Yuan Lai; Ruey-Jane Fan; Chao-Jung Lo; Yu-Mei Chou; Rekha Thiruvengadam; Andrew H-J Wang; Min-Ying Wang
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

7.  Assessment of Antibody Interference of Enfuvirtide (T20) Function Shows Assay Dependent Variability.

Authors:  Michele Smith; Jonathon Hoffman; Hakimuddin Sojar; Ravikumar Aalinkeel; Chiu-Bin Hsiao; Mark Daniel Hicar
Journal:  Curr HIV Res       Date:  2018       Impact factor: 1.581

8.  Selection, characterization and application of new RNA HIV gp 120 aptamers for facile delivery of Dicer substrate siRNAs into HIV infected cells.

Authors:  Jiehua Zhou; Piotr Swiderski; Haitang Li; Jane Zhang; C Preston Neff; Ramesh Akkina; John J Rossi
Journal:  Nucleic Acids Res       Date:  2009-03-21       Impact factor: 16.971

9.  Punica granatum (Pomegranate) juice provides an HIV-1 entry inhibitor and candidate topical microbicide.

Authors:  A Robert Neurath; Nathan Strick; Yun-Yao Li; Asim K Debnath
Journal:  BMC Infect Dis       Date:  2004-10-14       Impact factor: 3.090

10.  Growth and replication of infectious bursal disease virus in the DF-1 cell line and chicken embryo fibroblasts.

Authors:  Kaliyaperumal Rekha; Chandran Sivasubramanian; Ill-Min Chung; Muthu Thiruvengadam
Journal:  Biomed Res Int       Date:  2014-05-14       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.